In all patients where a pathogenic variant in TBX4 was detected, the clinical expressivity was highly variable, including an initial suspicion of PVOD, interstitial lung disease, pulmonary vascular abnormalities, and CHD. This evidence concerns the gene TBX4 and interstitial lung disease.